408 related articles for article (PubMed ID: 37174123)
21. MicroRNA Profiles in Hematopoietic Stem Cell Transplant Recipients.
Mohanraj L; Carter C; Liu J; Swift-Scanlan T
Biol Res Nurs; 2024 May; ():10998004241257847. PubMed ID: 38819871
[No Abstract] [Full Text] [Related]
22. The role of microRNAs in normal and malignant hematopoiesis.
Vasilatou D; Papageorgiou S; Pappa V; Papageorgiou E; Dervenoulas J
Eur J Haematol; 2010 Jan; 84(1):1-16. PubMed ID: 19744129
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs in hematological malignancies.
Lawrie CH
Blood Rev; 2013 May; 27(3):143-54. PubMed ID: 23623930
[TBL] [Abstract][Full Text] [Related]
24. The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies.
Vertès AA
Regen Med; 2015; 10(3):345-73. PubMed ID: 25933242
[TBL] [Abstract][Full Text] [Related]
25. Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes.
Kuang X; Chi J; Wang L
Hematology; 2016 Dec; 21(10):593-602. PubMed ID: 27357100
[TBL] [Abstract][Full Text] [Related]
26. [Relationship between microRNA-155 and hematological malignancies].
Xue H; Hua LM; Luo JM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):810-4. PubMed ID: 23815946
[TBL] [Abstract][Full Text] [Related]
27. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
28. Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation.
Bertaina A; Roncarolo MG
Front Immunol; 2019; 10():1342. PubMed ID: 31354695
[TBL] [Abstract][Full Text] [Related]
29. microRNAs: Key Players in Hematopoiesis.
Raghuwanshi S; Karnati HK; Sarvothaman S; Gutti U; Saladi RG; Tummala PR; Gutti RK
Adv Exp Med Biol; 2015; 887():171-211. PubMed ID: 26662992
[TBL] [Abstract][Full Text] [Related]
30. The functions and clinical significance of circRNAs in hematological malignancies.
Zhou X; Zhan L; Huang K; Wang X
J Hematol Oncol; 2020 Oct; 13(1):138. PubMed ID: 33069241
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Li T; Luo C; Zhang J; Wei L; Sun W; Xie Q; Liu Y; Zhao Y; Xu S; Wang L
Stem Cell Res Ther; 2021 Apr; 12(1):246. PubMed ID: 33879242
[TBL] [Abstract][Full Text] [Related]
32. MicroRNAs are shaping the hematopoietic landscape.
Bissels U; Bosio A; Wagner W
Haematologica; 2012 Feb; 97(2):160-7. PubMed ID: 22058204
[TBL] [Abstract][Full Text] [Related]
33. Association of
Li J; Seligson N; Zhang X; Johnson J; Vangundy Z; Wang D; Phelps M; Hofmeister C; Sadee W; Poi MJ
Anticancer Res; 2020 Oct; 40(10):5707-5713. PubMed ID: 32988896
[TBL] [Abstract][Full Text] [Related]
34. Targeting microRNA in hematologic malignancies.
Han Z; Rosen ST; Querfeld C
Curr Opin Oncol; 2020 Sep; 32(5):535-544. PubMed ID: 32657797
[TBL] [Abstract][Full Text] [Related]
35. Haploidentical Transplantation with Post-Transplant Cyclophosphamide versus Unrelated Donor Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Arcuri LJ; Aguiar MTM; Ribeiro AAF; Pacheco AGF
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2422-2430. PubMed ID: 31386903
[TBL] [Abstract][Full Text] [Related]
36. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.
Gailhouste L; Ochiya T
Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781
[TBL] [Abstract][Full Text] [Related]
37. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease.
Zhao L; Chen S; Yang P; Cao H; Li L
Stem Cell Res Ther; 2019 Jun; 10(1):182. PubMed ID: 31227011
[TBL] [Abstract][Full Text] [Related]
38. [Progress of study on circulating microRNAs in hematologic malignancies].
Qu Y; He HY; Hou J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):219-22. PubMed ID: 24598682
[TBL] [Abstract][Full Text] [Related]
39. Role of microRNAs in gynecological pathology.
Gilabert-Estelles J; Braza-Boils A; Ramon LA; Zorio E; Medina P; Espana F; Estelles A
Curr Med Chem; 2012; 19(15):2406-13. PubMed ID: 22455593
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA expression and function in cancer.
Garzon R; Fabbri M; Cimmino A; Calin GA; Croce CM
Trends Mol Med; 2006 Dec; 12(12):580-7. PubMed ID: 17071139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
